deltatrials
Completed NA INTERVENTIONAL 3-arm NCT00628121

Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer

Clinical Pharmacological Study of NS75A for Healthy Adult Women

Sponsor: AEterna Zentaris

Conditions Premenopause
Interventions Cetrorelix
Updated 5 times since 2017 Last updated: Feb 25, 2008 Started: Apr 30, 2006 Completion: Feb 28, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00628121, this NA trial focuses on Premenopause and remains completed. Sponsored by AEterna Zentaris, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2019 · 25 months · monthly snapshotCompleted~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Feb 2019 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Feb 2019 [monthly]

    Completed NA

    First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AEterna Zentaris
  • Nippon Kayaku Co., Ltd.
  • Shionogi
Data source: Nippon Kayaku Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations